Gilberto Lopes - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Gilberto Lopes's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Gilberto Lopes
Verified
Editor-in-Chief, Journal of Global Oncology
Miami
Beats
energy,Health environment, fiction writing drama, medicine
Anything outside of the above.
Content
By Rahul Gosain, Rohit Gosain, Gilberto Lopes| Targeted Oncology Verified September 19, 2024By Panelists discuss how the SKIPPirr data outcomes presented at World Conference for Lung Cancer 2024 provide valuable insights into the potential use of amivantamab for advancing lung cancer treatment strategies. Related Content Strategies for Neoadjuvant NSCLC TreatmentSeptember 1st 2023PodcastIn season 4, episode 13 of Targeted Talks, Benny Weskler, MBA, MD, FACS, FACCP, discusses neoadjuvant therapy for patients with non–small cell lung cancer.
By Gilberto Lopes| Pressenza in English Verified From the common house to the new iron curtainBy Gilberto LopesIt is December 2014 and a year ago the Maidan protests forced a change of government in Ukraine. Mikhail Gorbachev, the then 83-year-old president of the Soviet Union (USSR), spoke to Pilar Bonet, a Moscow correspondent for the Spanish daily El País for 34 years. “The construction of the common European house is more urgent than ever,” Gorbachev told her.
By Rahul Gosain, Rohit Gosain, Gilberto Lopes| Targeted Oncology Verified September 19, 2024By Panelists discuss how the SKIPPirr data outcomes presented at World Conference for Lung Cancer 2024 provide valuable insights into the potential use of amivantamab for advancing lung cancer treatment strategies. Related Content Strategies for Neoadjuvant NSCLC TreatmentSeptember 1st 2023PodcastIn season 4, episode 13 of Targeted Talks, Benny Weskler, MBA, MD, FACS, FACCP, discusses neoadjuvant therapy for patients with non–small cell lung cancer.
Company Info
Journal of Global Oncology
Alexandria, Virginia, United States
+1 571-483-1300